Keyphrases
Critically Ill Pediatric Patients
66%
Stabilization Period
66%
Hemophagocytic Lymphohistiocytosis
66%
Atypical Hemolytic Uremic Syndrome (aHUS)
66%
Complication Prevention
66%
Respiratory Failure
66%
Cytomegalovirus Infection
66%
Air Transport
66%
Eculizumab
66%
Pediatric Severe Sepsis
66%
Febrile children
66%
Regulatory Variants
66%
Meningococcal Disease
66%
Genetic Susceptibility
66%
Multisystem Inflammatory Syndrome in children (MIS-C)
66%
Clinical Definition
66%
Plasma Lipid Profile
66%
Point Prevalence Survey
66%
Consensus Criteria
66%
Viral Infection
66%
Bacterial Infection
66%
Polymorphism
50%
Physician Diagnosis
47%
Pediatric
42%
Severe Sepsis
38%
Peripheral Line
33%
Neurological Involvement
33%
Cardiopulmonary Resuscitation
33%
Hemodynamic Compromise
33%
Patient Transport
33%
Transport Unit
33%
Critical Patient
33%
Anticonvulsant
33%
Neurological Disorders
33%
Pleural Drainage
33%
Low Dose Rate
33%
Preparation Phase
33%
Minor Complications
33%
Major Complications
33%
Serious Complications
33%
Mechanical Ventilation
33%
Hemodynamic Instability
33%
Virus
33%
Disease Susceptibility
33%
Kawasaki Disease
28%
Pediatric Intensive Care Unit
28%
Diagnostic Criteria
19%
Breastfeeding Duration
19%
Immunological Diseases
16%
Ganciclovir
16%
Medicine and Dentistry
Pediatrics
100%
Pediatrics Patient
71%
Hemodynamic
66%
Eculizumab
66%
Hemophagocytic Syndrome
66%
Atypical Hemolytic Uremic Syndrome
66%
Cytomegalovirus Infection
66%
Sepsis
66%
Serositis
66%
Prevalence
66%
Genetic Susceptibility
66%
Meningococcal Disease
66%
Kawasaki Disease
50%
Infection
50%
Respiratory Failure
33%
Disease Predisposition
33%
Intensive Care
26%
Intensive Care Unit
26%
Diseases
25%
Artificial Respiration
16%
Vasoactive Agent
16%
Anticonvulsant
16%
Neurologic Disease
16%
Ganciclovir
16%
Resuscitation
16%
Central Venous Catheter
16%
Heparin
16%
Plasmapheresis
16%
Kidney Function
16%
Immunopathology
16%
Isoprenaline
16%
Intracardiac Thrombosis
16%
Continuous Hemodiafiltration
16%
Plasma Transfusion
16%
Cefotaxime
16%
Microangiopathy
16%
Fibrinogen
16%
Methylprednisolone
16%
Autoimmune Disease
16%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Prophylaxis
16%
Genetic Code
16%
Childhood Disease
16%
Epithelial Cell
16%
Genetic Risk
16%
Genetic Association
16%
Regulatory Region
16%
Single Nucleotide Polymorphism
16%
DNA Binding
16%
Binding Site
16%
